News|Articles|September 15, 2023

Celebrating Hispanic Heritage Month 2023

September 15 to October 15 is Hispanic Heritage Month. To celebrate, here’s a look at some recent coverage in Psychiatric Times® on how clinicians can improve psychiatric care for Latinx patients.

Newsletter

Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.

Subscribe

Related Content

Unified Treatment Model Shows Long-Term Symptom Gains in BIPOC Patients With Eating Disorders

ByLeah Kuntz

July 31st 2026

Bipolar Disorder in Women of Childbearing Age: Proper Treatment Before Pregnancy

ByAshley A. Mulvihill, MD ,Susan Hatters Friedman, MD, MSt, DFAPA

July 17th 2026

Zuranolone in the Room: Closing the Gap in Postpartum Depression Care

ByLeslie Williams, MD

July 16th 2026

Presenting Our June 2026 Theme: Special Populations

ByLeah Kuntz

June 1st 2026

Importance of Monitoring Patients’ Hormonal Contraceptive Use

ByAnastasia Makhanova, PhD,Mikayla DM Joslin, MA,Summer Mengelkoch, PhD

April 21st 2026

Latest CME

Video

(CME Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Gus Alva, MD, DFAPA; Ilan Melnick, MD

Video

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Jason Kellogg, MD; Gus Alva, MD, DFAPA; Melanie Barrett, MD; Yvette Elpidio, MSN, FNP-C

Video

Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care

John Koo, MD; T.J. Chao, MPAS, PA-C

Video

Expert Illustrations & Commentary: Visualizing the Role of Novel Muscarinic Agents in the Management of Schizophrenia

Ilan Melnick, MD; Linda Collado, MD, DABPN, FAPA; Maria Collado, MD, FAPA

Video

Expert Illustrations & Commentary: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Juan D. Oms, MD, FAPA; Linda Collado, MD, DABPN, FAPA; Ginger Shupe, MD

Video

(CPE Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Gus Alva, MD, DFAPA; Ilan Melnick, MD

Video

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Jason Kellogg, MD; Gus Alva, MD, DFAPA; Melanie Barrett, MD; Yvette Elpidio, MSN, FNP-C

Celebrating Hispanic Heritage Month 2023

Related Content

Unified Treatment Model Shows Long-Term Symptom Gains in BIPOC Patients With Eating Disorders

Bipolar Disorder in Women of Childbearing Age: Proper Treatment Before Pregnancy

Zuranolone in the Room: Closing the Gap in Postpartum Depression Care

Presenting Our June 2026 Theme: Special Populations

Importance of Monitoring Patients’ Hormonal Contraceptive Use

Latest CME

(CME Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care

Expert Illustrations & Commentary: Visualizing the Role of Novel Muscarinic Agents in the Management of Schizophrenia

Expert Illustrations & Commentary: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

(CPE Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Trending on Psychiatric Times

FDA Feedback Paves Way for New IND Filing for PT00114 in Generalized Anxiety Disorder

A Practical Role for Long-Acting Buprenorphine in Opioid Use Disorder Care

Kratom Component in Clinical Trial for Opioid Use Disorder

Psyched Perspectives: ADHD in Underrecognized Populations, With Paige Walton, MD

Objective Measurement for Psychiatry: Universal Brain's ERP System